Friday, May 26, 2017 1:44:53 PM
1. Comprised of numerous cannabis companies including AXIM Biotech.
2. MJNA has already hit ~50 cents in 2013 and in 2014. (Float & O/S weren't "low" then either.)
3. Some of MJNA's CBD competitors are over $1.00 in their PPSs.
4. MJNA is located in California (world's 6th largest economy) where rec. MJ just became legal.
5. MJNA is poised and well-positioned to enter legal MJ market.
6. High exposure to Wall Street investors via 2 recent Forbes write ups.
7. Lot of U.S. and foreign media coverage on MJNA and it's products in 2016.
8. Highly effective MJNA CBD products used for medical illnesses in USA and over 40 countries.
9. MJNA's HempMeds product is "prescribed" as a medical drug in several countries.
10. New VP of Ops "grew sales to $50 million" in 5 years where he worked previously.
11. CNBC's Steve Grasso and his firm are LONG on MJNA.
12. Potential for big well-known Wall Street investors to invest in MJNA.
13. MJNA just came out with 2016 fins: $8M total income; $4.6M gross profit.
IN MY OPINION
"The stock market is a device for transferring money from the impatient to the patient" — Warren Buffett
"The Big Money is not in the buying and the selling but in the waiting" — Charlie Munger
FEATURED Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • May 16, 2024 8:13 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM
HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM
Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • INTV • May 15, 2024 10:30 AM
Swifty Global Announces Impressive Financial Results for Q1 2024 • DRCR • May 15, 2024 10:25 AM